Skip to content

Clinical research of controlled ovarian stimulation using MPA and HMG in women with PCOS

Clinical research of controlled ovarian stimulation using MPA and HMG in women with PCOS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICC-15006042
Enrollment
Unknown
Registered
2015-03-05
Start date
2015-03-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

Control:Short schedual
Experimental:HMG 225IU/d, MPA 10mg/d begin at 2-3 days of menstruation

Sponsors

Shanghai Ninth People's Hospital Affiliated to JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: PCOS patients according to the Rotterdam, age 25 to 40, characterized by high testerone,anovulation and PCO.

Exclusion criteria

Exclusion criteria: 1. documented ovarian failure including basal FSH above 10 IU/l or no antral follicles by ultrasound examination; 2. endometriosis grade 3 or higher; 3. presence of afunctional ovarian cyst with E2>100pg/ml; 4. received hormonal treatments in the previous three months; 5. any contraindications to ovarian stimulation treatment.

Design outcomes

Primary

MeasureTime frame
number of oocytes retrieved;

Secondary

MeasureTime frame
number of mature oocytes;Number of Fertilization;number of cleavage;The number of embryos available;The number of frozen embryos;the incidence of premature LH surge and clinical pregnancy outcomes from FETs;The change trend of FSH, LH, E2, P and T in the process of ovulation;

Countries

China

Contacts

Public ContactYun Wang
sammy20080228@aliyun.com+86 021-23271699-5538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026